We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Multiplex Nested PCR Detects Bloodstream Candida Species

By LabMedica International staff writers
Posted on 14 Aug 2014
A multiplex nested polymerase chain reaction (PCR) method has been developed to detect and identify seven Candida species in peripheral blood samples of critically ill pediatric patients.

Nosocomial candidaemia is associated with high mortality rates in critically ill pediatric and neonatal patients and therefore the early detection and identification of the infectious fungal agent is crucial for successful medical intervention.

Clinical microbiologists at the University of Sao Paulo (Butanta, Brazil) enrolled 54 consecutive pediatric patients, among whom there were 24 neonates, admitted to the intensive care unit (ICU) of two pediatric referral hospitals in Sao Paulo State (Brazil). More...
The patients presented with systemic inflammatory response syndrome (SIRS) and at least two predisposing conditions/risk factors for the development of candidaemia. A control group included 28 children that had no evidence of any type of bloodstream infection and had undergone minor surgical procedures during the same time.

Blood samples were taken and either cultured or had DNA extracted. The 54 DNA samples were evaluated by multiplex nested PCR with specific primers designed to identify seven Candida species, and the results were compared with those obtained from blood cultures.

The extracted DNA samples were amplified and the reactions were carried out in a Veriti thermocycler (Applied Biosystems; Carlsbad, CA, USA). The nested PCR products were detected on 2.5% agarose gels and visualized under a UV transilluminator apparatus (UVITEC; Cambridge, UK).

The multiplex nested PCR had a detection limit of four Candida genomes/mL of blood for all Candida species. Blood cultures were positive in 14.8% of patients, whereas the multiplex nested PCR was positive in 24.0% of patients, including all culture-positive patients. The results obtained with the molecular technique were available within 24 hours, and the assay was able to identify Candida species with 100% of concordance with blood cultures. Additionally the multiplex nested PCR detected dual candidaemia in three patients. Candida albicans was the most frequently isolated species in blood cultures (five out of eight positive results), while the multiplex nested PCR identified C. albicans, C. parapsilosis complex, and C. tropicalis at similar frequencies.

The authors concluded that multiplex PCR assay targeting the intergenic space region (ITS) of Candida ribosomal DNA was able to identify the main Candida species involved in bloodstream pediatric infections with a detection limit of less than 10 colony forming units (CFU)/mL. The assay had high specificity, and is as least as sensitive as blood cultures but with a shorter turnaround time. The use of the multiplex nested PCR method also allowed the detection and identification of one or more Candida species in the same reaction. The study was published on July 21, 2014, in the journal BMC Infectious Diseases.

Related Links:
University of Sao Paulo
Applied Biosystems
UVITEC



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Serological Pipet Controller
PIPETBOY GENIUS
New
Rapid Test Reader
DIA5000
New
Staining System
RAL DIFF-QUIK
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
Image: Pancreatic cancer diagnosis (Photo courtesy of World Journal of Gastroenterology)

AI-Driven Preliminary Testing for Pancreatic Cancer Enhances Prognosis

Pancreatic cancer poses a major global health threat due to its high mortality rate, with 467,409 deaths and 510,992 new cases reported worldwide in 2022. Often referred to as the "king" of all cancers,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.